Skip to main content
FSCDR 2025 Annual Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestream
Livestream
On Demand
On Demand
Meal
Meal
Ticketed Event
Ticketed Event

Session: Abstract Breakout Session I Clinical / Clinical Trials

Clinical and Laboratory Outcomes During Versus After EPO Treatment in Patients with Sickle Cell Disease: Insights from ACHiEvE-SCD

Sunday, June 8, 2025
2:30 PM - 2:45 PM ET
Location: 303A

Learning Objectives:

  • Discuss the rationale for using EPO to manage anemia in SCD patients and summarize the safety and efficacy data from the study
  • Recognize the financial and systemic challenges affecting EPO use in low-resource settings, as highlighted by the study’s findings.
  • Formulate potential research questions to further investigate the long-term effects of EPO on transfusion needs, quality of life, and functional capacity in SCD patients.
  • Assess the impact of 12-week EPO treatment on hemoglobin levels, LDH, indirect bilirubin, tranfusion and VOE rates in SCD patients.